Morgan Stanley Knock-Out BGNE/ DE000MB80XF1 /
| 2024-05-22 10:20:29 AM | Chg.+0.23 | Bid10:53:51 AM | Ask10:53:41 AM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 6.57EUR | +3.63% | 6.56 Bid Size: 200 |
- Ask Size: - |
BeiGene Ltd | 99.4163 - | 2078-12-31 | Call |
GlobeNewswire
2020-08-05
BeiGene Announces Data on Tislelizumab and Pamiparib to Be Presented at the 2020 European Society fo...
GlobeNewswire
2020-07-27
Priority Review Granted to BeiGene’s New Drug Application of Pamiparib in Ovarian Cancer in China
GlobeNewswire
2020-07-17
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in Ovarian Cancer in China
GlobeNewswire
2020-07-15
BeiGene Announces Closing of Approximately $2.08 Billion Registered Direct Offering
GlobeNewswire
2020-07-13
BeiGene Announces Pricing of Approximately $2.08 Billion Registered Direct Offering
GlobeNewswire
2020-07-02
BeiGene to Host Investor Conference Call and Webcast to Discuss the Company’s Early Development Pipe...
GlobeNewswire
2020-07-02
BeiGene Announces Acceptance of a Supplemental New Drug Application for Tislelizumab in Patients wit...
GlobeNewswire
2020-06-19
BeiGene Announces Acceptance of a Supplemental New Drug Application for Tislelizumab in Combination ...
GlobeNewswire
2020-06-18
BeiGene Announces European Medicines Agency Acceptance of its Marketing Authorization Application fo...
GlobeNewswire
2020-06-12
BeiGene Presents Clinical Data on Zanubrutinib and Tislelizumab at the 25th European Hematology Asso...
GlobeNewswire
2020-06-05
BeiGene to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
GlobeNewswire
2020-06-03
BeiGene Announces the Approval of BRUKINSA™ (Zanubrutinib) in China for Patients with Relapsed/Refra...
GlobeNewswire
2020-05-29
BeiGene Presents Updated Head to Head Results from Phase 3 Trial of Zanubrutinib vs. Ibrutinib in Pa...
GlobeNewswire
2020-05-29
BeiGene Presents Phase 3 Data on Tislelizumab Combined with Chemotherapy for the Treatment of Patien...
GlobeNewswire
2020-05-26
BeiGene to Host Investor Conference Call and Webcast to Discuss Clinical Study Results Presented at ...
GlobeNewswire
2020-05-21
BeiGene and Medison Pharma Announce Exclusive Distribution Agreement and Acceptance of New Drug Appl...
GlobeNewswire
2020-05-20
BeiGene to Present at the Bernstein 36th Annual Strategic Decisions Conference
GlobeNewswire
2020-05-15
BeiGene Announces Clinical and Preclinical Data to Be Presented at the 2020 American Association for...
GlobeNewswire
2020-05-14
BeiGene Announces Clinical and Non-Clinical Data on BRUKINSA™ (Zanubrutinib) and Tislelizumab to Be ...
